Assistance Publique-Hôpitaux de Paris, Hôpital Paul Brousse
France

Contact Information for physicians and patients
Centre Hépato-Biliaire
Hôpital Universitaire Paul Brousse
12-14 avenue Paul Vaillant Couturier
F-94800 Villejuif
France
Particular rare liver disease expertise of the centre
The CHB takes care of several rare liver diseases:
AIH, PBC, PSC, biliary atresia, Alagille syndrome, Wilson Disease, liver diseases in pregnancy, iron overload diseases, alpha-1 antitrypsin deficiency, vascular liver diseases, Rendu-Osler, genetic cholestasis, ALF for rare liver diseases, vascular liver diseases, familial amyloid neuropathy, NET, rare liver tumors, biliary malformations, choledochal cyst, intrahepatic cholangiocarcinoma.
- Primary Biliary Cholangitis (PBC)
- Autoimmune Hepatitis (AIH)
- Primary Sclerosing Cholangitis (PSC)
- IgG4-related Liver Disease
- Cystic Liver Disease
- Vascular Liver Disease
- Rare Liver Tumours
- Liver Disease in Pregnancy
ERN Representatives
-
Dr. Eleonora De Martin
-
Prof. Jean-Charles Duclos-Vallée
ERN Team and Contact
- Dr DE MARTIN Eleonora – eleonora.demartin(at)aphp.fr
- Mlle FERRI Aurélia – aurelia.ferri(at)aphp.fr
Centre information
The Centre Hépato-Biliaire (CHB) at Paul Brousse Hospital is set to take care of patients with liver and biliary diseases providing a multidisciplinary approach. Hepatologists, hepato-biliary surgeons, radiologists, pathologists, anesthesiologist and intensive care specialists as well as a highly specialized paramedical staff work daily together as a team to ensure the best management of patients with liver diseases. The CHB is a reference center for several rare liver diseases, in particular autoimmune diseases, Wilson’s disease, familial amyloid neuropathy, vascular liver diseases, biliary atresia. An educational program is available for the patients and we work closely with patient’s associations. The CHB is the first liver transplantation center in France with about 130-160 liver transplantations per year. The CHB offers a transition program to young adults with liver diseases and transplanted patients who move from pediatric to adult care service. In parallel with the clinical activity, the center had an intense clinical and experimental research program.